PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
53.86
ESG score 80-90% of Healthcare median of 61.06. Martin Whitman would look for hidden ESG liabilities and regulatory risks.
51.34
Environmental score 80-90% of Healthcare median of 58.20. Martin Whitman would look for hidden carbon liabilities and stranded asset risks.
52.89
Social score 80-90% of Healthcare median of 63.19. Martin Whitman would look for hidden social liabilities and reputational risks.
57.36
Governance score 90-95% of Healthcare median of 61.27. John Neff would demand higher returns to compensate for below-average governance oversight.